Investigation of fatal human Borna disease virus 1 encephalitis outside the previously known area for human cases, Brandenburg, Germany - a case report.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
10 Aug 2021
Historique:
received: 07 07 2020
accepted: 15 07 2021
entrez: 11 8 2021
pubmed: 12 8 2021
medline: 25 9 2021
Statut: epublish

Résumé

The true burden and geographical distribution of human Borna disease virus 1 (BoDV-1) encephalitis is unknown. All detected cases so far have been recorded in Bavaria, southern Germany. A retrospective laboratory and epidemiological investigation of a 2017 case of fatal encephalitis in a farmer in Brandenburg, northeast Germany, demonstrated BoDV-1 as causative agent by polymerase chain reaction, immunohistochemistry and in situ hybridization. Next-generation sequencing showed that the virus belonged to a cluster not known to be endemic in Brandenburg. The investigation was triggered by a recent outbreak of animal Borna disease in the region. Multiple possible exposures were identified. The next-of-kin were seronegative. The investigation highlights clinical awareness for human BoDV-1 encephalitis which should be extended to all areas endemic for animal Borna disease. All previously diagnosed human cases had occurred > 350 km further south. Further testing of shrews and livestock with Borna disease may show whether this BoDV-1 cluster is additionally endemic in the northwest of Brandenburg.

Sections du résumé

BACKGROUND BACKGROUND
The true burden and geographical distribution of human Borna disease virus 1 (BoDV-1) encephalitis is unknown. All detected cases so far have been recorded in Bavaria, southern Germany.
CASE PRESENTATION METHODS
A retrospective laboratory and epidemiological investigation of a 2017 case of fatal encephalitis in a farmer in Brandenburg, northeast Germany, demonstrated BoDV-1 as causative agent by polymerase chain reaction, immunohistochemistry and in situ hybridization. Next-generation sequencing showed that the virus belonged to a cluster not known to be endemic in Brandenburg. The investigation was triggered by a recent outbreak of animal Borna disease in the region. Multiple possible exposures were identified. The next-of-kin were seronegative.
CONCLUSIONS CONCLUSIONS
The investigation highlights clinical awareness for human BoDV-1 encephalitis which should be extended to all areas endemic for animal Borna disease. All previously diagnosed human cases had occurred > 350 km further south. Further testing of shrews and livestock with Borna disease may show whether this BoDV-1 cluster is additionally endemic in the northwest of Brandenburg.

Identifiants

pubmed: 34376142
doi: 10.1186/s12879-021-06439-3
pii: 10.1186/s12879-021-06439-3
pmc: PMC8353434
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

787

Subventions

Organisme : Bundesministerium für Bildung und Forschung
ID : 01KI1722A/C/E

Informations de copyright

© 2021. The Author(s).

Références

N Engl J Med. 2018 Oct 4;379(14):1377-1379
pubmed: 30281984
Emerg Infect Dis. 2021 May;27(5):1371-1379
pubmed: 33900167
Lancet Infect Dis. 2020 Apr;20(4):467-477
pubmed: 31924550
PLoS Pathog. 2019 Aug 1;15(8):e1007873
pubmed: 31369648
Emerg Microbes Infect. 2017 Jun 21;6(6):e52
pubmed: 28634359
Emerg Infect Dis. 2018 Jun;24(6):978-987
pubmed: 29774846
J Comp Pathol. 2010 Aug-Oct;143(2-3):203-8
pubmed: 20153871
Neuropathol Appl Neurobiol. 2008 Dec;34(6):590-602
pubmed: 18282160
N Engl J Med. 2015 Jul 9;373(2):154-62
pubmed: 26154788
Drugs. 2013 Feb;73(2):131-58
pubmed: 23377760
Acta Neuropathol. 2019 Jun;137(6):1017-1019
pubmed: 30953131
Acta Neuropathol. 2019 Oct;138(4):653-665
pubmed: 31346692
N Engl J Med. 2018 Oct 4;379(14):1375-1377
pubmed: 30281979
PLoS One. 2015 Aug 27;10(8):e0137018
pubmed: 26313904
J Gen Virol. 2005 Feb;86(Pt 2):385-398
pubmed: 15659758
PLoS One. 2014 Apr 03;9(4):e93659
pubmed: 24699636
Rev Med Virol. 2007 May-Jun;17(3):181-203
pubmed: 17342788
Transbound Emerg Dis. 2020 Mar 29;:
pubmed: 32223069
Vet Rec. 2011 Apr 9;168(14):380b
pubmed: 21498268

Auteurs

Dennis Tappe (D)

Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Str. 74, 20359, Hamburg, Germany. tappe@bnitm.de.

Kirsten Pörtner (K)

Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Postgraduate Training for Applied Epidemiology (PAE) affiliated with the European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.

Christina Frank (C)

Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.

Hendrik Wilking (H)

Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.

Arnt Ebinger (A)

Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Riems, Germany.

Christiane Herden (C)

Institute for Veterinary Pathology, Justus-Liebig-University Gießen, Gießen, Germany.

Christoph Schulze (C)

Landeslabor Berlin-Brandenburg, Frankfurt (Oder), Germany.

Birgit Muntau (B)

Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Str. 74, 20359, Hamburg, Germany.

Petra Eggert (P)

Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Str. 74, 20359, Hamburg, Germany.

Petra Allartz (P)

Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Str. 74, 20359, Hamburg, Germany.

Gerlind Schuldt (G)

Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Str. 74, 20359, Hamburg, Germany.

Jonas Schmidt-Chanasit (J)

Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Str. 74, 20359, Hamburg, Germany.

Martin Beer (M)

Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Riems, Germany.

Dennis Rubbenstroth (D)

Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Riems, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH